Home > Insider Trading > Filing (0001209191-20-007477)

Filing Details

Accession Number:: 0001209191-20-007477
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-07 16:08:54
Reporting Period:: 2020-02-05

Accepted Time:: 2020-02-07 16:08:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557290	A Stuart Arbuckle	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-05	12,136	$0.00	45,376	No	4	A	Direct
Common Stock	Acquisiton	2020-02-05	9,800	$0.00	55,176	No	4	A	Direct
Common Stock	Acquisiton	2020-02-05	12,387	$0.00	67,563	No	4	A	Direct
Common Stock	Acquisiton	2020-02-06	1,564	$187.53	69,127	No	4	M	Direct
Common Stock	Acquisiton	2020-02-06	1,223	$155.57	70,350	No	4	M	Direct
Common Stock	Disposition	2020-02-06	1,511	$238.71	68,839	No	4	S	Direct
Common Stock	Disposition	2020-02-06	725	$239.47	68,114	No	4	S	Direct
Common Stock	Disposition	2020-02-06	230	$240.53	67,884	No	4	S	Direct
Common Stock	Disposition	2020-02-06	150	$241.08	67,734	No	4	S	Direct
Common Stock	Disposition	2020-02-06	171	$242.47	67,563	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-06	1,564	$0.00	1,564	$187.53
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-06	1,223	$0.00	1,223	$155.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,770		2029-02-05	No	4	M	Direct
9,783		2028-02-05	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	140	Indirect	401(k)

Footnotes

Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020.
Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020.
Restricted stock unit award that vests in installments beginning on 02/10/2021.
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $238.71 (range $238.07 to $239.05).
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $239.47 (range $239.11 to $240.04).
Open market sales reported on this line occurred at a weighted average price of $240.53 (range $240.40 to $240.60).
Open market sales reported on this line occurred at a weighted average price of $241.08 (range $241.04 to $241.12).
The option vests in 16 quarterly installments from 02/06/2019.
The option vests in 16 quarterly installments from 02/06/2018.